NZ215865A
(en)
*
|
1985-04-22 |
1988-10-28 |
Commw Serum Lab Commission |
Method of determining the active site of a receptor-binding analogue
|
ATE165363T1
(de)
*
|
1985-08-28 |
1998-05-15 |
George Pieczenik |
Verfahren und mittel zur sortierung und bestimmung biologischer informationen
|
US5866363A
(en)
|
1985-08-28 |
1999-02-02 |
Pieczenik; George |
Method and means for sorting and identifying biological information
|
US5041381A
(en)
|
1986-07-03 |
1991-08-20 |
Schering Corporation |
Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
|
US6222020B1
(en)
*
|
1987-01-07 |
2001-04-24 |
Imperial Cancer Research Technology Limited |
Antigens derived from the core protein of the human mammary epithelial mucin
|
US5300425A
(en)
*
|
1987-10-13 |
1994-04-05 |
Terrapin Technologies, Inc. |
Method to produce immunodiagnostic reagents
|
US5338659A
(en)
*
|
1991-04-02 |
1994-08-16 |
Terrapin Technologies, Inc. |
Method for determining analyte concentration by cross-reactivity profiling
|
ATE152244T1
(de)
*
|
1987-10-13 |
1997-05-15 |
Terrapin Tech Inc |
Verfahren zur herstellung von imunodiagnose- mitteln
|
US5599903A
(en)
*
|
1992-04-03 |
1997-02-04 |
Terrapin Technologies, Inc. |
Glutathione analogs and paralog panels comprising glutathione mimics
|
US5133866A
(en)
*
|
1988-03-24 |
1992-07-28 |
Terrapin Technologies, Inc. |
Method to identify analyte-bending ligands
|
US5217869A
(en)
*
|
1987-10-13 |
1993-06-08 |
Terrapin Technologies, Inc. |
Method to produce immunodiagnostic reagents
|
GB8810400D0
(en)
|
1988-05-03 |
1988-06-08 |
Southern E |
Analysing polynucleotide sequences
|
US5409611A
(en)
*
|
1988-03-24 |
1995-04-25 |
Terrapin Technoogies, Inc. |
Method to identify analyte-binding ligands
|
US5340474A
(en)
*
|
1988-03-24 |
1994-08-23 |
Terrapin Technologies, Inc. |
Panels of analyte-binding ligands
|
US5266684A
(en)
*
|
1988-05-02 |
1993-11-30 |
The Reagents Of The University Of California |
Peptide mixtures
|
US5225533A
(en)
*
|
1988-05-02 |
1993-07-06 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
US5010175A
(en)
*
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
US6054270A
(en)
*
|
1988-05-03 |
2000-04-25 |
Oxford Gene Technology Limited |
Analying polynucleotide sequences
|
US7811751B2
(en)
|
1988-05-03 |
2010-10-12 |
Oxford Gene Technology Limited |
Analysing polynucleotide sequences
|
US5700637A
(en)
*
|
1988-05-03 |
1997-12-23 |
Isis Innovation Limited |
Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
|
FR2631451A1
(fr)
*
|
1988-05-13 |
1989-11-17 |
Inst Nat Sante Rech Med |
Procede de caracterisation de l'epitope intervenant dans une reaction antigene anticorps, kit ou necessaire pour la mise en oeuvre du procede
|
US5286789A
(en)
*
|
1989-05-26 |
1994-02-15 |
Applied Immune Sciences, Inc. |
Solid phase multiple peptide synthesis
|
US5547839A
(en)
|
1989-06-07 |
1996-08-20 |
Affymax Technologies N.V. |
Sequencing of surface immobilized polymers utilizing microflourescence detection
|
US5527681A
(en)
*
|
1989-06-07 |
1996-06-18 |
Affymax Technologies N.V. |
Immobilized molecular synthesis of systematically substituted compounds
|
US5143854A
(en)
*
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
US20030225254A1
(en)
*
|
1989-08-07 |
2003-12-04 |
Rathjen Deborah Ann |
Tumour necrosis factor binding ligands
|
US5959087A
(en)
*
|
1989-08-07 |
1999-09-28 |
Peptide Technology, Ltd. |
Tumour necrosis factor binding ligands
|
AU640400B2
(en)
*
|
1989-08-07 |
1993-08-26 |
Peptide Technology Ltd. |
Tumour necrosis factor binding ligands
|
US5747334A
(en)
*
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
US5498538A
(en)
*
|
1990-02-15 |
1996-03-12 |
The University Of North Carolina At Chapel Hill |
Totally synthetic affinity reagents
|
US5811387A
(en)
*
|
1990-05-15 |
1998-09-22 |
Chiron Corporation |
Peptoid mixtures
|
US5182366A
(en)
*
|
1990-05-15 |
1993-01-26 |
Huebner Verena D |
Controlled synthesis of peptide mixtures using mixed resins
|
US5252296A
(en)
*
|
1990-05-15 |
1993-10-12 |
Chiron Corporation |
Method and apparatus for biopolymer synthesis
|
US5650489A
(en)
*
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
US6197529B1
(en)
|
1990-11-21 |
2001-03-06 |
Torrey Pines Institute For Molecular Studies |
Linear substituted oligoalkyleneimine libraries
|
EP0558671B1
(de)
*
|
1990-11-21 |
1999-01-27 |
Iterex Pharmaceuticals Ltd. Partnership |
Synthese äquimolarer mischungen vielzähliger oligomere, speziell oligopeptidmischungen
|
ATE173297T1
(de)
*
|
1991-04-29 |
1998-11-15 |
Terrapin Tech Inc |
Verfahren zur erkennung und behandlung anomaler zellen
|
US5786336A
(en)
*
|
1991-04-29 |
1998-07-28 |
Terrapin Technologies, Inc. |
Target-selective protocols based on mimics
|
EP0639227A1
(de)
*
|
1991-05-07 |
1995-02-22 |
Oxford Glycosciences (Uk) Limited |
Sequenzierung von oligosacchariden
|
TW304957B
(de)
*
|
1991-06-18 |
1997-05-11 |
Lilly Co Eli |
|
US5747253A
(en)
*
|
1991-08-23 |
1998-05-05 |
Isis Pharmaceuticals, Inc. |
Combinatorial oligomer immunoabsorbant screening assay for transcription factors and other biomolecule binding
|
WO1993004204A1
(en)
*
|
1991-08-23 |
1993-03-04 |
Isis Pharmaceuticals, Inc. |
Synthetic unrandomization of oligomer fragments
|
US5698391A
(en)
*
|
1991-08-23 |
1997-12-16 |
Isis Pharmaceuticals, Inc. |
Methods for synthetic unrandomization of oligomer fragments
|
US6943034B1
(en)
|
1991-11-22 |
2005-09-13 |
Affymetrix, Inc. |
Combinatorial strategies for polymer synthesis
|
US5955432A
(en)
*
|
1992-04-03 |
1999-09-21 |
Terrapin Technologies, Inc. |
Metabolic effects of certain glutathione analogs
|
US5541061A
(en)
*
|
1992-04-29 |
1996-07-30 |
Affymax Technologies N.V. |
Methods for screening factorial chemical libraries
|
US5591646A
(en)
*
|
1992-09-02 |
1997-01-07 |
Arris Pharmaceutical |
Method and apparatus for peptide synthesis and screening
|
US6582902B1
(en)
*
|
1992-09-30 |
2003-06-24 |
Jack D. Keene |
Method for deriving epitopes
|
US5877278A
(en)
*
|
1992-09-24 |
1999-03-02 |
Chiron Corporation |
Synthesis of N-substituted oligomers
|
US6503759B1
(en)
|
1992-10-01 |
2003-01-07 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5721099A
(en)
*
|
1992-10-01 |
1998-02-24 |
Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5565324A
(en)
*
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5565325A
(en)
*
|
1992-10-30 |
1996-10-15 |
Bristol-Myers Squibb Company |
Iterative methods for screening peptide libraries
|
US5807683A
(en)
*
|
1992-11-19 |
1998-09-15 |
Combichem, Inc. |
Combinatorial libraries and methods for their use
|
DE4308410A1
(de)
*
|
1993-03-12 |
1994-09-15 |
Schering Ag |
Verfahren zur Synthese und Selektionierung von Sequenzen aus kovalent verbundenen Bausteinen
|
AU6281594A
(en)
*
|
1993-03-12 |
1994-09-26 |
Jerini Bio Chemicals Gmbh |
Process for synthesizing and selecting sequences of covalently bound components
|
US6864048B2
(en)
*
|
1993-04-28 |
2005-03-08 |
Affymetrix, Inc. |
Factorial chemical libraries
|
IT1270939B
(it)
*
|
1993-05-11 |
1997-05-26 |
Angeletti P Ist Richerche Bio |
Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
|
US5367053A
(en)
*
|
1993-05-19 |
1994-11-22 |
Houghten Pharmaceuticals, Inc. |
Opioid peptide inhibitors
|
US5846731A
(en)
*
|
1993-06-17 |
1998-12-08 |
Torry Pines Institute For Molecular Studies |
Peralkylated oligopeptide mixtures
|
US6008058A
(en)
*
|
1993-06-18 |
1999-12-28 |
University Of Louisville |
Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
|
US5380668A
(en)
*
|
1993-07-06 |
1995-01-10 |
University Of Utah Research Foundation |
Compounds having the antigenicity of hCG
|
US5908919A
(en)
*
|
1993-10-01 |
1999-06-01 |
Terrapin Technologies |
Urethane mediated, GST specific molecular release systems
|
CN1525171A
(zh)
*
|
1993-10-01 |
2004-09-01 |
ŦԼ�и��ױ��Ǵ�ѧ���� |
用标示物编码的多元组合化学库
|
WO1995010296A1
(en)
*
|
1993-10-12 |
1995-04-20 |
Glycomed Incorporated |
A library of glyco-peptides useful for identification of cell adhesion inhibitors
|
WO1995013538A1
(en)
*
|
1993-11-12 |
1995-05-18 |
Operon Technologies, Inc. |
Methods of producing and screening complex chemical libraries
|
US5492807A
(en)
*
|
1993-11-19 |
1996-02-20 |
Santi; Daniel V. |
Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
WO1995019567A1
(en)
*
|
1994-01-13 |
1995-07-20 |
The Trustees Of Columbia University In The City Of New York |
Synthetic receptors, libraries and uses thereof
|
US6660276B1
(en)
|
1994-02-16 |
2003-12-09 |
The University Of Virginia Patent Foundation |
Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
|
US6936477B2
(en)
*
|
1994-04-13 |
2005-08-30 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5738996A
(en)
*
|
1994-06-15 |
1998-04-14 |
Pence, Inc. |
Combinational library composition and method
|
US5824483A
(en)
*
|
1994-05-18 |
1998-10-20 |
Pence Inc. |
Conformationally-restricted combinatiorial library composition and method
|
US5846841A
(en)
*
|
1994-05-20 |
1998-12-08 |
Selectide Corporation |
Motif Libraries
|
US5582997A
(en)
*
|
1994-08-24 |
1996-12-10 |
Torrey Pines Institute For Molecular Studies |
Lysine/leucine polypeptides, mixture sets and libraries thereof
|
US5645996A
(en)
*
|
1994-08-24 |
1997-07-08 |
Torrey Pines Institute For Molecular Studies |
Melittin-related polypeptides, mixture sets and libraries thereof
|
US7597886B2
(en)
*
|
1994-11-07 |
2009-10-06 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US7820798B2
(en)
*
|
1994-11-07 |
2010-10-26 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US5958792A
(en)
*
|
1995-06-07 |
1999-09-28 |
Chiron Corporation |
Combinatorial libraries of substrate-bound cyclic organic compounds
|
US5747458A
(en)
*
|
1995-06-07 |
1998-05-05 |
Chiron Corporation |
Urokinase receptor ligands
|
US5763263A
(en)
*
|
1995-11-27 |
1998-06-09 |
Dehlinger; Peter J. |
Method and apparatus for producing position addressable combinatorial libraries
|
EP1283212A1
(de)
*
|
1995-12-18 |
2003-02-12 |
Praecis Pharmaceuticals Incorporated |
Verfahren zum Nachweis von Verbindungen die bestimmte Zielmoleküle binden
|
GB9609262D0
(en)
*
|
1996-05-02 |
1996-07-03 |
Isis Innovation |
Peptide library and method
|
AU731123B2
(en)
|
1996-08-16 |
2001-03-22 |
Human Genome Sciences, Inc. |
Human endokine alpha
|
AU7155296A
(en)
|
1996-08-30 |
1998-03-19 |
Human Genome Sciences, Inc. |
Interleukin-19
|
WO1998014569A1
(en)
|
1996-10-02 |
1998-04-09 |
Bloch Donald B |
Leukocyte-specific protein and gene, and methods of use thereof
|
EP0939804B2
(de)
|
1996-10-25 |
2011-06-15 |
Human Genome Sciences, Inc. |
NEUTROKIN alpha
|
US6413724B1
(en)
|
1996-10-28 |
2002-07-02 |
Versicor, Inc. |
Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
|
US6025371A
(en)
*
|
1996-10-28 |
2000-02-15 |
Versicor, Inc. |
Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
|
EP0941335A2
(de)
|
1996-10-31 |
1999-09-15 |
Human Genome Sciences |
Polynukleotide und sequenzen aus streptococcus pneumoniae
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
CA2276462C
(en)
|
1996-12-31 |
2007-06-12 |
Genometrix Incorporated |
Multiplexed molecular analysis system apparatus and method
|
WO1999014240A1
(en)
|
1997-09-17 |
1999-03-25 |
Human Genome Sciences, Inc. |
Interleukin-17 receptor-like protein
|
MXPA00004256A
(es)
|
1997-11-03 |
2005-07-01 |
Human Genome Sciences Inc |
Inhibidor de las celulas endoteliales vasculares, un inhibidor de la angiogenesis y crecimiento del tumor.
|
WO1999027078A1
(en)
*
|
1997-11-21 |
1999-06-03 |
Human Genome Sciences, Inc. |
Chemokine alpha-5
|
US20030096232A1
(en)
|
1997-12-19 |
2003-05-22 |
Kris Richard M. |
High throughput assay system
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
CA2318969A1
(en)
|
1998-01-23 |
1999-07-29 |
Mikhail F. Gordeev |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
CA2323776C
(en)
|
1998-03-19 |
2010-04-27 |
Human Genome Sciences, Inc. |
Cytokine receptor common gamma chain like
|
PT1129354E
(pt)
*
|
1998-11-13 |
2008-11-11 |
Pepscan Systems Bv |
Um método para determinar uma sequência de mimotopo
|
CA2363779A1
(en)
|
1999-02-26 |
2000-08-31 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
US9289487B2
(en)
*
|
1999-09-14 |
2016-03-22 |
Antigen Express, Inc. |
II-key/antigenic epitope hybrid peptide vaccines
|
US6432409B1
(en)
*
|
1999-09-14 |
2002-08-13 |
Antigen Express, Inc. |
Hybrid peptides modulate the immune response
|
US6545032B1
(en)
|
1999-09-17 |
2003-04-08 |
Torrey Pines Institute For Molecular Studies |
Synthesis of [3,5,7]-H-imidazo[1,5-a] imidazol-2(3H)-one compounds
|
EP1232264B1
(de)
|
1999-11-18 |
2009-10-21 |
Novartis Vaccines and Diagnostics, Inc. |
Menschliches fgf-21 gen und genexpressionsprodukte
|
EP2075255A1
(de)
|
2000-03-08 |
2009-07-01 |
Novartis Vaccines and Diagnostics, Inc. |
Menschliche FGF-23-Gene und Genexpressionsprodukte
|
US20020110843A1
(en)
*
|
2000-05-12 |
2002-08-15 |
Dumas David P. |
Compositions and methods for epitope mapping
|
US6759510B1
(en)
|
2000-06-30 |
2004-07-06 |
Becton, Dickinson And Company |
Peptides for use in culture media
|
AUPR279101A0
(en)
*
|
2001-01-30 |
2001-02-22 |
Cytopia Pty Ltd |
Protein kinase signalling
|
EP2123749A3
(de)
|
2001-02-23 |
2010-02-24 |
DSM IP Assets B.V. |
Neuartige Gene zur Kodierung von neuartigen proteolytischen Enzymen
|
CA2444632A1
(en)
|
2001-04-13 |
2002-10-24 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US20030013208A1
(en)
*
|
2001-07-13 |
2003-01-16 |
Milagen, Inc. |
Information enhanced antibody arrays
|
WO2003076585A2
(en)
|
2002-03-08 |
2003-09-18 |
Board Of Regents, The University Of Texas System |
Controlled modulation of amino acid side chain length of peptide antigens
|
ES2347550T3
(es)
|
2002-05-21 |
2010-11-02 |
Dsm Ip Assets B.V. |
Nuevas fosfolipasas y usos de las mismas.
|
EP1530630A2
(de)
*
|
2002-08-19 |
2005-05-18 |
DSM IP Assets B.V. |
Neue lipasen und deren verwendung
|
AU2003259995B2
(en)
|
2002-08-28 |
2009-07-02 |
Immunex Corporation |
Compositions and methods for treating cardiovascular disease
|
EP1556072B1
(de)
|
2002-09-17 |
2010-05-19 |
Antigen Express, Inc. |
Ii-key/antigene epitop-hybrid-peptid-vakzine
|
US7179645B2
(en)
*
|
2002-09-24 |
2007-02-20 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
US6910785B2
(en)
*
|
2003-01-22 |
2005-06-28 |
Cooper Technologies Company |
Industrial luminaire with prismatic refractor
|
US20040185499A1
(en)
*
|
2003-03-20 |
2004-09-23 |
Jolley Michael E. |
Method of epitope scanning using fluorescence polarization
|
WO2005012530A2
(en)
|
2003-07-25 |
2005-02-10 |
Amgen Inc. |
Antagonists and agonists of ldcam and methods of use
|
US7396940B2
(en)
|
2003-10-23 |
2008-07-08 |
Hoffmann-La Roche Inc. |
Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
|
US20050095648A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Mario Geysen |
Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
|
EP2479277B1
(de)
|
2004-07-22 |
2015-09-02 |
Five Prime Therapeutics, Inc. |
Verwendung von MGD-CDF zur Behandlung der Alzheimer's Krankheit
|
US8945573B2
(en)
|
2005-09-08 |
2015-02-03 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Targeted identification of immunogenic peptides
|
US20120208824A1
(en)
|
2006-01-20 |
2012-08-16 |
Cell Signaling Technology, Inc. |
ROS Kinase in Lung Cancer
|
EP1973946B1
(de)
|
2006-01-20 |
2015-03-25 |
Cell Signaling Technology, Inc. |
Translokation und mutations-ros-kinase bei menschlichem nicht-kleinzelligem lungenkrebs
|
HUE035732T2
(en)
|
2006-04-14 |
2018-05-28 |
Cell Signaling Technology Inc |
Gene defects and mutant ALK kinase in human solid tumors
|
WO2008100596A2
(en)
*
|
2007-02-15 |
2008-08-21 |
Burnham Institute For Medical Research |
Biomarkers of neurodegenerative disease
|
EP2139460A4
(de)
|
2007-03-20 |
2011-09-07 |
Univ Brandeis |
Zusammensetzungen und verfahren zur diagnose, behandlung und prävention von amyotropher lateralsklerose und assoziierten neurologischen erkrankungen
|
EP2185688A4
(de)
|
2007-08-06 |
2010-08-25 |
Burnham Inst Medical Research |
Znf206: ein neuer regulator der selbsterneuerung und pluripotenz embryonaler stammzellen
|
EP2203558B1
(de)
|
2007-10-18 |
2016-05-04 |
Cell Signaling Technology, Inc. |
Translokation und mutations-ros-kinase bei menschlichem nicht-kleinzelligem bronchialkarzinom
|
AU2009262199B2
(en)
|
2008-06-27 |
2012-08-09 |
Amgen Inc. |
Ang-2 inhibition to treat multiple sclerosis
|
JP2012516350A
(ja)
*
|
2009-01-28 |
2012-07-19 |
アンティジェン・エクスプレス・インコーポレーテッド |
インフルエンザに対する免疫応答を調節するIi−Keyハイブリッドペプチド
|
HUE035769T2
(en)
|
2009-02-12 |
2018-05-28 |
Cell Signaling Technology Inc |
Mutant ROS expression in human liver cancer
|
WO2011025394A1
(en)
|
2009-08-27 |
2011-03-03 |
Pastoral Greenhouse Gas Research Ltd |
Complete genome sequence of the methanogen methanobrevibacter ruminantium
|
US20120101108A1
(en)
|
2010-08-06 |
2012-04-26 |
Cell Signaling Technology, Inc. |
Anaplastic Lymphoma Kinase In Kidney Cancer
|
HUE037856T2
(hu)
|
2012-04-18 |
2018-09-28 |
Cell Signaling Technology Inc |
EGFR és ROS1 rákban
|
US10155987B2
(en)
|
2012-06-12 |
2018-12-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of predicting resistance to JAK inhibitor therapy
|
AU2019236328A1
(en)
*
|
2018-03-16 |
2020-09-10 |
Zoetis Services Llc |
Peptide vaccines against Interleukin-31
|